a

1. Medtronic gets FTC's OK for Covidien deal

Written by Laura Dyrda | Wednesday, 26 November 2014 00:00
The Federal Trade Commission cleared Medtronic to merge with Covidien, according to a Wall Street Journal report.
The Food and Drug Administration granted 40 spine- and orthopedic-related device clearances in October.

3. 10 core concepts for the surgical navigation systems market

Written by Laura Dyrda | Wednesday, 26 November 2014 00:00
The surgical navigation systems market is expected to grow in revenue over the next three years, according to a report from BCC Research.
Centinel Spine released the MIDLINE II, its next generation STALIF Family Lumbar Integrated Interbody fusion device.

5. 10 key thoughts on the spinal non-fusion device market

Written by Laura Dyrda | Wednesday, 26 November 2014 00:00
The spinal non-fusion devices market is expected to grow over the next four years, according to a Transparency Markets Research report.
The advanced orthopedic technologies, implants and regenerative products market is expected to make significant changes over the next four years, according to a BCC Research report. 
Stryker's stock hit a 52-week high earlier this week as company anticipates another opportunity to acquire Smith & Nephew over the next few weeks, according to a Digital Journal report.

8. DRT Medical to build new $4.6M facility — 5 things to know

Written by Laura Dyrda | Wednesday, 26 November 2014 00:00
DRT Medical, a medical manufacturer based in Dayton, Ohio, is planning a new research and development facility in West Chester, according to a Dayton Business Journal report.

9. Oxford Performance Materials gets $150k NIH grant

Written by Laura Dyrda | Wednesday, 26 November 2014 00:00
Oxford Performance Materials received a three-year, $150,000 grant from the National Institutes of Health, according to a Today's Medical Developments report.
Orthofix participated in a NASDAQ Hearings Panel related to the company's delayed filing and reporting of quarterly financial reports.

11. Alphatec Spine to attend 2 investor conferences in December

Written by Anuja Vaidya | Tuesday, 25 November 2014 00:00
Alphatec Spine announced Jim Corbett, the company's president and CEO, and Mike O'Neill, CFO, will participate in the Piper Jaffray 26th Annual Healthcare Conference, Dec. 2 to 3 in New York as well as the Oppenheimer 25th Annual Healthcare Conference, Dec. 10 and 11, also in New York.
Interventional Spine received U.S. Food and Drug Administration clearance for its Lateral Opticage Expandable Intervertebral Body Fusion Device.

13. Alphatec Spine adds Tom Davis to board of directors

Written by Anuja Vaidya | Tuesday, 25 November 2014 00:00
Alphatec Spine appointed Tom C. Davis to its board of directors.
Stryker may soon make the long-discussed bid for Smith & Nephew in what could be another tax inversion strategy that further changes the orthopedic device landscape.
Aurora Spine presented at the Brean Capital Life Sciences Summit Conference in New York on Nov. 24.
Ceterix Orthopaedics announced enrollment of the first patient in a study evaluating a suture-based meniscal repair for patients with horizontal meniscus tears called STITCH.
Implanet signed six new distribution agreements in the wake of the North American Spine Society annual meeting.
Spineology received a patent for a percutaneous spinal interbody fusion system and performance method.

19. LDR to present at 2 New York-based investor conferences

Written by Anuja Vaidya | Friday, 21 November 2014 00:00
LDR will be participating in the Piper Jaffray 26th Annual Healthcare Conference, Dec. 2 to 3 in New York, as well as the Brean Capital Life Sciences Summit, Nov. 24, also in New York.
Covidien CEO Jose Almeida received $49 million after selling the company to Medtronic, accourding to a Southern Business Journal report.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 176